MEI Pharma Competitors and Similar CompaniesClear all
ESSA Pharma's competitors and similar companies include Sunesis Pharmaceuticals, Takeda and Puma Biotechnology.
 ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. |  Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers. |  Takeda Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | |
Founding Date | Founding Date 2009 | Founding Date 1987 | Founding Date 1781 | Founding Date 2010 |
Type | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations Vancouver, CA HQ Houston, US South San Francisco, US | Locations South San Francisco, US HQ | Locations Los Angeles, US HQ | |
Employees | Employees 50 | Employees 43 | Employees 49,281 | Employees 27214% decrease |
Valuation ($) | Valuation ($) 240 m | Valuation ($) N/A | Valuation ($) 43.7 b | Valuation ($) 136.8 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥4.3t (FY, 2024) | Revenue (est.) $235.6m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥698.7b (FY, 2024) | Cost of goods $62.7m (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥3.6t (FY, 2024) | Gross profit $173m (FY, 2023) |
Net income | Net income ($26.6m) (FY, 2023) | Net income ($114.8m) (FY, 2021) | Net income ¥144.2b (FY, 2024) | Net income $21.6m (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised $ 74.1m | Total funding raised $ 171.7m | Total funding raised $ 57.8m | Total funding raised $ 172m |
For sources of this data, please see the company profile
View Company Profiles
Sunesis Pharmaceuticals
HQ
South San Francisco, US
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
View companyTakeda
HQ
Tokyo, JP
Employees
49,281
Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyPuma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company